C4 Therapeutics
CCCC
Reported
Thursday, February 27
Q4 2024 Earnings
| (USD) | Expected | Reported | Surprise $ | Surprise % |
|---|---|---|---|---|
| EPS | -0.37 | -0.49 | -0.12 | -32.43% |
| Revenue | 3.60M | 5.18M | 1.58M | 43.81% |
WhatIF - Earnings
EPS Missed Expectations by -$0.12
C4 Therapeutics (CCCC:NASDAQ) has never missed EPS by this much before
There’s a first time for everything